Connection

Charles Bennett to Fibrinolytic Agents

Back to Details
This is a "connection" page, showing publications Charles Bennett has written about Fibrinolytic Agents.
Charles Bennett
Connection Strength
1.036
Fibrinolytic Agents
  1. Adverse effects of drugs on hemostasis and thrombosis. Semin Thromb Hemost. 2012 Nov; 38(8):755-8.
    View in: PubMed
    Score: 0.321
  2. Thromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR). Semin Thromb Hemost. 2012 Nov; 38(8):759-67.
    View in: PubMed
    Score: 0.320
  3. Low-molecular-weight heparins: do we have the GUSTO to identify differences between alternative formulations? Arch Intern Med. 2005 Apr 11; 165(7):722-3.
    View in: PubMed
    Score: 0.190
  4. Cost-effectiveness considerations in the treatment of essential thrombocythemia. Semin Oncol. 2002 Jun; 29(3 Suppl 10):28-32.
    View in: PubMed
    Score: 0.156
  5. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost. 2005 Dec; 31(6):681-90.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.